TLR4 and pulmonary arterial hypertension: Certain organisms such as Lactobacillus reuteri have been found to reduce pro-inflammatory cytokine levels and inhibit TLR4 signalling through the NF-kB pathway, as well as modifying pathophysiological changes in animal models of PAH [65,66].